Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified perioperative indometacin analgesia during pancreaticoduodenectomy
DRKS00011321Phase 2Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indomethacin, sponsored by Universitätsklinikum Freiburg. Primary endpoint: Safety of modified perioperative analgesia with indometacin. Started Jun 2017; status: completed.
02
Drugs
indomethacin
Beyond the preview
Go deeper on DRKS00011321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00011321.